author-photo

Pashalina Kehagias

Université libre de Bruxelles

12

Papers

28

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

Abstract 28: Prognostic value of baseline and early changes of circulating cell-free (cf)DNA in the neoadjuvant setting of early stage colon cancer (CC)

2021
Show All
- Source
- Cite
- Save
Citations (0)
Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer.

2021 Acta Oncologica
Show All
- Source
- Cite
- Save
Citations (0)
18F-FDG PET scan and liquid biopsy as tools to assess the pace of tumor progression and to predict overall survival (OS) in refractory colorectal cancer (rCRC): The CORIOLAN trial.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Prognostic Value of the Pace of Tumor Progression as Assessed by Serial 18F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial

2020 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel.

2020 Acta Oncologica
Show All
- Source
- Cite
- Save
Citations (0)
Combining 18F-FDG PET/CT-based Metabolically Active Tumor Volume and Circulating Cell-free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer

2019 The Journal of Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (7)
Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor

2018 Oncotarget
Show All
- Source
- Cite
- Save
Citations (19)
Abstract LB-221: Circulating tumor DNA detects early response to regorafenib in advanced colorectal cancer

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
ctDNA Increase May Predict Regorafenib Response in Advanced CRC

2018
- Pashalina Kehagias
Show All
- Source
- Cite
- Save
Citations (0)
Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)